MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 341556 | Name: Naranol hydrochloride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Naranol hydrochloride is a biochemical.

Chemical Structure

Naranol hydrochloride
Naranol hydrochloride
CAS#34256-91-2

Theoretical Analysis

MedKoo Cat#: 341556

Name: Naranol hydrochloride

CAS#: 34256-91-2

Chemical Formula: C18H22ClNO2

Exact Mass: 319.1339

Molecular Weight: 319.83

Elemental Analysis: C, 67.60; H, 6.93; Cl, 11.08; N, 4.38; O, 10.00

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Naranol hydrochloride; W 5494A; W-5494A; W5494A; W 5494 A.
IUPAC/Chemical Name
7aH-Naphtho(1',2':5,6)pyrano(3,2-c)pyridin-7a-ol, 8,9,10,11,11a,12-hexahydro-8,10-dimethyl-, hydrochloride
InChi Key
IBSSDTOGUGCBDB-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H21NO2.ClH/c1-12-10-19(2)11-14-9-16-15-6-4-3-5-13(15)7-8-17(16)21-18(12,14)20;/h3-8,12,14,20H,9-11H2,1-2H3;1H
SMILES Code
OC12C(CC3=C4C=CC=CC4=CC=C3O2)CN(C)CC1C.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 319.83 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lin HW, Simonavice CA, Lu CR, Lin WL, Wu PL, Chou CY, Liao CH, Lane HY. Severe hypertriglyceridemia secondary to venlafaxine use in an older adult on dialysis -case report. BMC Health Serv Res. 2017 Apr 13;17(1):272. doi: 10.1186/s12913-017-2195-2. PubMed PMID: 28407764; PubMed Central PMCID: PMC5390401. 2: Kaufman MB, Pham T, Parameswaran L, Choy M. Prasugrel hypersensitivity with respiratory distress and rash. Am J Health Syst Pharm. 2016 Jul 15;73(14):1051-7. doi: 10.2146/ajhp150327. PubMed PMID: 27385702. 3: McKean J, Watts H, Mokszycki R. Breakthrough seizures after starting vilazodone for depression. Pharmacotherapy. 2015 Mar;35(3):e6-8. doi: 10.1002/phar.1549. PubMed PMID: 25809181. 4: Štuhec M. Excessive sweating induced by interaction between agomelatine and duloxetine hydrochloride: case report and review of the literature. Wien Klin Wochenschr. 2015 Sep;127(17-18):703-6. doi: 10.1007/s00508-014-0688-0. Epub 2015 Jan 10. Review. PubMed PMID: 25576334. 5: Ferreira PG, Costa S, Dias N, Ferreira AJ, Franco F. Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine. J Bras Pneumol. 2014 May-Jun;40(3):313-8. English, Portuguese. PubMed PMID: 25029655; PubMed Central PMCID: PMC4109204. 6: Williams MF, Maloof JA 3rd. Resolution of clopidogrel-associated polyarthritis after conversion to prasugrel. Am J Health Syst Pharm. 2014 Jul 1;71(13):1097-100. doi: 10.2146/ajhp130518. PubMed PMID: 24939499. 7: Iuppa CA, Diefenderfer LA. Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine. Ann Pharmacother. 2013 Sep;47(9):1223-8. doi: 10.1177/1060028013503132. PubMed PMID: 24259741. 8: Angelo LJ, Lee KC. Dose-related paresthesias with venlafaxine. J Pharm Pract. 2013 Oct;26(5):514-7. doi: 10.1177/0897190013489573. Epub 2013 Jun 13. PubMed PMID: 23764565. 9: Kaufman KR, Podolsky D, Greenman D, Madraswala R. Antidepressant-selective gynecomastia. Ann Pharmacother. 2013 Jan;47(1):e6. doi: 10.1345/aph.1R491. Epub 2013 Jan 16. PubMed PMID: 23324513. 10: Ruggiero S, Rafaniello C, Bravaccio C, Grimaldi G, Granato R, Pascotto A, Sportiello L, Parretta E, Rinaldi B, Panei P, Rossi F, Capuano A. Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. J Child Adolesc Psychopharmacol. 2012 Dec;22(6):415-22. doi: 10.1089/cap.2012.0003. PubMed PMID: 23234585. 11: Nazer LH, Shankar G, Ali BA, Al-Najjar T. Fatal agranulocytosis associated with psychotropic medication use. Am J Health Syst Pharm. 2012 May 15;69(10):863-7. doi: 10.2146/ajhp110195. PubMed PMID: 22555081. 12: Kruithof MK, Bruins NA, van Roon EN. Coma after overdose with duloxetine. Ann Pharmacother. 2011 Jan;45(1):e5. doi: 10.1345/aph.1P432. Epub 2010 Dec 21. PubMed PMID: 21177420. 13: Steidl KE, Darko W, Probst LA, Noviasky JA, Nasser S. Rhabdomyolysis associated with phentermine. Am J Health Syst Pharm. 2010 Nov 15;67(22):1929-32. doi: 10.2146/ajhp090395. PubMed PMID: 21048209. 14: Prlesi L, Plakogiannis R. Angioedema after nonsteroidal antiinflammatory drug initiation in a patient stable on an angiotensin-converting-enzyme inhibitor. Am J Health Syst Pharm. 2010 Aug 15;67(16):1351-3. doi: 10.2146/ajhp090348. PubMed PMID: 20689124. 15: Charniot JC, Vignat N, Monsuez JJ, Kidouche R, Avramova B, Artigou JY, Albertini JP. Cardiogenic shock associated with reversible dilated cardiomyopathy during therapy with regular doses of venlafaxine. Am J Emerg Med. 2010 Feb;28(2):256.e1-5. doi: 10.1016/j.ajem.2009.05.010. PubMed PMID: 20159409. 16: Kelesidis T, Kelesidis I. Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin. Clin Ther. 2009 Dec;31(12):2894-9. doi: 10.1016/j.clinthera.2009.12.008. PubMed PMID: 20110028. 17: Glance LE, Cumpston A, Kanate A, Remick SC. Bendamustine-associated hemolytic anemia. Ann Pharmacother. 2009 Nov;43(11):1903-6. doi: 10.1345/aph.1M329. Epub 2009 Oct 6. PubMed PMID: 19809007. 18: Giannikopoulos G, Zorzou MP, Stamoulis I, Panagi G, Sitaras P, Georgopoulos I, Hadjileontis C, Malakos I, Kyriazis J. Cinacalcet-induced leukocytoclastic vasculitis. Am J Kidney Dis. 2009 Aug;54(2):e5-8. doi: 10.1053/j.ajkd.2009.02.019. Epub 2009 Jun 28. PubMed PMID: 19560849. 19: Stevens DL. Duloxetine-associated tachycardia. Ann Pharmacother. 2008 Oct;42(10):1511-3. doi: 10.1345/aph.1L108. Epub 2008 Aug 26. PubMed PMID: 18728105. 20: Colucci VJ, Berry BD. Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy. Ann Pharmacother. 2008 Jun;42(6):882-7. doi: 10.1345/aph.1L031. Epub 2008 Apr 29. PubMed PMID: 18445706.